-
公开(公告)号:USRE37078E1
公开(公告)日:2001-02-27
申请号:US09368343
申请日:1999-08-03
IPC分类号: A61K3138
CPC分类号: C07D333/24
摘要: The invention relates to thiophene compounds of formula: wherein: X1, X2, Y1 and Y2, which are identical or different, each represents hydrogen or halogen, (C1-C5)-alkyl or alkoxy, or trifluoromethyl, X1 and Y1, which are identical or different, each represents C1-C5 alkoxy, X2 and Y2 each represents hydrogen, R1 represents hydrogen or (C1-C5)-alkyl, A represents a straight (C1-C5)-hydrocarbon chain of which each carbon atom is optionally mono- or di-substituted by a (C1-C5)-alkyl, and R2 represents hydrogen, (C1-C6)-alkyl, cyclohexyl or benzyl; and their physiologically tolerable salts. The products of the invention may be used as anti-inflammatory agents.
摘要翻译: 本发明涉及下式的噻吩化合物:其中:相同或不同的X1,X2,Y1和Y2各自表示氢或卤素,其中:
X1和Y1, 它们相同或不同,各自表示C1-C5烷氧基,X2和Y2各自表示氢,R1表示氢或(C1-C5) - 烷基,A表示直链 (C 1 -C 5) - 烃链,其中每个碳原子任选被(C 1 -C 5) - 烷基单取代或二取代,R 2表示氢,(C 1 -C 6) - 烷基,环己基或苄基; 本发明的产品可以用作抗炎剂。 -
公开(公告)号:US5175294A
公开(公告)日:1992-12-29
申请号:US740075
申请日:1991-08-05
IPC分类号: C07D333/20 , C07D333/24
CPC分类号: C07D333/20 , C07D333/24
摘要: New thiophene compounds of the formula: ##STR1## in which: X represents hydrogen, halogen, C.sub.1 -C.sub.5 alkyl or alkoxy or dialkylamino;n represents 1 or 2;a represents an integer of from 2 to 6;b represents 2 or 3;c represents 1 or 2, and is such that b+c=4;R.sub.1 and R.sub.2 represent hydrogen or (C.sub.1 -C.sub.5)alkyl, or together with the carbon atom to which they are bonded form a hydrocarbon ring containing from 3 to 6 carbon atoms; andR and R' represent hydrogen or (C.sub.1 -C.sub.5)alkyl, or together with the nitrogen atom to which they are bonded form a pentagonal or hexagonal heterocycle optionally containing an oxygen atom or a second nitrogen atom which may itself be substituted; and their physiologically tolerable salts.The products of the invention can be used therapeutically especially in the treatment of pathologies that are characterized by a loss of bone tissue.As new intermediate products used in the synthesis of the compounds I above defined, the amides of the formula: ##STR2## in which: X, n, a, b, c, R.sub.1, R.sub.2, R and R' are as above defined.
摘要翻译: 新的具有下式的噻吩化合物:其中:X表示氢,卤素,C 1 -C 5烷基或烷氧基或二烷基氨基; n表示1或2; a表示2〜6的整数, b表示2或3; c表示1或2,并且b + c = 4; R1和R2表示氢或(C1-C5)烷基,或与它们所键合的碳原子一起形成含有3至6个碳原子的烃环; 并且R和R'表示氢或(C1-C5)烷基,或与它们所键合的氮原子一起形成任选地含有氧原子的五价或六价杂环或本身可被取代的第二氮原子; 及其生理上可耐受的盐。 本发明的产品可以治疗特别用于治疗以组织损失为特征的病理学。 作为上述化合物I的合成中使用的新的中间产物,下式的酰胺如下:其中:X,n,a,b,c,R 1,R 2,R和R'如上所定义。
-
公开(公告)号:US5705525A
公开(公告)日:1998-01-06
申请号:US605537
申请日:1996-02-22
IPC分类号: A61K31/38 , A61K31/381 , A61P1/00 , A61P17/00 , A61P29/00 , C07D333/24 , C07D333/16 , C07D333/20
CPC分类号: C07D333/24
摘要: The invention relates to thiophene compounds of formula: ##STR1## wherein: X.sub.1, X.sub.2, Y.sub.1 and Y.sub.2, which are identical or different, each represents hydrogen or halogen, (C.sub.1 -C.sub.5)-alkyl or alkoxy, or trifluoromethyl, R.sub.1 represents hydrogen or (C.sub.1 -C.sub.5)-alkyl, A represents a straight (C.sub.1 -C.sub.5)-hydrocarbon chain of which each carbon atom is optionally mono- or di-substituted by a (C.sub.1 -C.sub.5)-alkyl, and R.sub.2 represents hydrogen, (C.sub.1 -C.sub.6)-alkyl, cyclohexyl or benzyl; and their physiologically tolerable salts. The products of the invention may be used as anti-inflammatory agents.
摘要翻译: 本发明涉及下式的噻吩化合物:其中:X 1,X 2,Y 1和Y 2相同或不同,各自表示氢或卤素,(C 1 -C 5) - 烷基或烷氧基或三氟甲基,R 1表示氢 或(C 1 -C 5) - 烷基,A表示直链(C 1 -C 5) - 烃链,其中每个碳原子任选被(C 1 -C 5) - 烷基单取代或二取代,并且R 2表示氢,( C 1 -C 6) - 烷基,环己基或苄基; 及其生理上可耐受的盐。 本发明的产品可以用作抗炎剂。
-
公开(公告)号:US5061704A
公开(公告)日:1991-10-29
申请号:US617501
申请日:1990-11-23
IPC分类号: A61K31/38 , A61K31/381 , A61K31/495 , A61K31/535 , A61K31/54 , A61P3/00 , A61P43/00 , C07D333/20 , C07D333/24
CPC分类号: C07D333/24 , C07D333/20
摘要: 1. New thiophene compounds of the formula: ##STR1## in which: X represents hydrogen, halogen, C.sub.1 -C.sub.5 alkyl or alkoxy or dialkylamino;n represents 1 or 2;a represents an integer of from 2 to 6;b represents 2 or 3;c represents 1 or 2, and is such that b+c=4;R.sub.1 and R.sub.2 represent hydrogen or (C.sub.1 -C.sub.5)alkyl, or together with the carbon atom to which they are bonded form a hydrocarbon ring containing from 3 to 6 carbon atoms; andR and R' represent hydrogen or (C.sub.1 -C.sub.5)alkyl, or together with the nitrogen atom to which they are bonded form a pentagonal or hexagonal heterocycle optionally containing an oxygen atom or a second nitrogen atom which may itself be substituted; and their physiologically tolerable salts.The products of the invention can be used therapeutically especially in the treatment of pathologies that are characterized by a loss of bone tissue.2. As new intermediate products used in the synthesis of the compounds I above defined, the amides of the formula: ##STR2## in which: X, n, a, b, c, R.sub.1, R.sub.2, R and R' are as above defined.
摘要翻译: 1.下式的新噻吩化合物:其中:X表示氢,卤素,C 1 -C 5烷基或烷氧基或二烷基氨基; n表示1或2; a表示2〜6的整数, b表示2或3; c表示1或2,并且b + c = 4; R1和R2表示氢或(C1-C5)烷基,或与它们所键合的碳原子一起形成含有3至6个碳原子的烃环; 并且R和R'表示氢或(C1-C5)烷基,或与它们所键合的氮原子一起形成任选地含有氧原子的五价或六价杂环或本身可被取代的第二氮原子; 及其生理上可耐受的盐。 本发明的产品可以治疗特别用于治疗以组织损失为特征的病理学。 2.作为合成上述化合物I的新中间体产物,下式的酰胺如下:其中:X,n,a,b,c,R1,R2,R和R'如上所述 定义
-
公开(公告)号:US5391569A
公开(公告)日:1995-02-21
申请号:US127804
申请日:1993-09-28
申请人: Jean-Daniel Brion , Guillaume Le Baut , Guillaume Poissonnet , Lucy De Montarby , Larbi Belachmi , Jacqueline Bonnet , Massimo Sabatini , Charles Tordjman
发明人: Jean-Daniel Brion , Guillaume Le Baut , Guillaume Poissonnet , Lucy De Montarby , Larbi Belachmi , Jacqueline Bonnet , Massimo Sabatini , Charles Tordjman
IPC分类号: A61K31/35 , A61K31/352 , A61K31/66 , A61P3/00 , A61P19/10 , A61P29/00 , A61P43/00 , C07D311/12 , C07D311/14 , C07D311/16 , C07D311/18 , C07D311/58 , C07D311/64 , C07D311/70 , C07D311/72 , C07D405/04 , C07D409/04 , C07F9/655 , A61K31/40 , A61K31/445 , A61K31/47
CPC分类号: C07D405/04 , C07D311/58 , C07D311/64 , C07D311/70 , C07D409/04
摘要: A compound selected from those of formula (I): ##STR1## in which the groups R.sub.1 to R.sub.8 are as defined the description. Medicaments.
摘要翻译: 选自式(I)的化合物:其中基团R1至R8如说明书所定义。 药剂
-
公开(公告)号:US06114360A
公开(公告)日:2000-09-05
申请号:US390416
申请日:1999-09-03
IPC分类号: A61K31/00 , A61K31/40 , A61K31/403 , A61K31/4035 , A61K31/407 , A61K31/415 , A61K31/4164 , A61K31/4178 , A61K31/44 , A61K31/4427 , A61K31/443 , A61K31/4433 , A61K31/4436 , A61K31/4439 , A61P19/00 , A61P19/02 , A61P29/00 , A61P43/00 , C07D209/44 , C07D209/52 , C07D209/72 , C07D401/04 , C07D401/14 , C07D403/10 , C07D403/14 , C07D405/14 , C07D409/04 , C07D409/14 , C07D487/04 , C07D491/16
CPC分类号: C07D401/14 , C07D209/44 , C07D209/52 , C07D209/72 , C07D405/14 , C07D409/04 , C07D409/14 , C07D487/04
摘要: Compounds of formula (I): ##STR1## wherein: R represents hydrogen, alkyl, optionally-substituted amino, or linear or branched (C.sub.1 -C.sub.6)-acyl,R.sub.1 and R.sub.2, which may be identical or different, each represents independently of the other aryl, heteroaryl, or (C.sub.5 -C.sub.7)-cycloalkyl, or one of those groups optionally substituted,A, together with the atoms in common with the pyrrole, represents saturated or unsaturated, monocyclic or bicyclic (C.sub.3 -C.sub.12)-cycloalkyl, or a saturated heterocycle having 5 to 7 ring members and containing one or two nitrogen, or 7-oxabicyclo[2.2.1] heptane, or one of those groups optionally substituted, their isomers, and also addition salts thereof with a pharmaceutically-acceptable acid or base, pharmaceutical compositions thereof, and use thereof as medicaments.
摘要翻译: 式(I)的化合物:其中:R表示氢,烷基,任选取代的氨基或直链或支链(C 1 -C 6) - 酰基,可以相同或不同的R 1和R 2各自独立地表示其它芳基 ,杂芳基或(C5-C7) - 环烷基,或任选取代的那些基团之一,A与与吡咯共同的原子一起代表饱和或不饱和的单环或双环(C 3 -C 12) - 环烷基或 饱和杂环,其具有5至7个环成员并含有一个或两个氮或7-氧杂双环[2.2.1]庚烷,或任选取代的那些基团之一,其异构体,以及其与药学上可接受的酸或碱的加成盐 ,其药物组合物及其作为药物的用途。
-
公开(公告)号:US6063804A
公开(公告)日:2000-05-16
申请号:US199640
申请日:1998-11-25
IPC分类号: A61K31/00 , A61K31/40 , A61K31/403 , A61K31/4035 , A61K31/407 , A61K31/415 , A61K31/4164 , A61K31/4178 , A61K31/44 , A61K31/4427 , A61K31/443 , A61K31/4433 , A61K31/4436 , A61K31/4439 , A61P19/00 , A61P19/02 , A61P29/00 , A61P43/00 , C07D209/44 , C07D209/52 , C07D209/72 , C07D401/04 , C07D401/14 , C07D403/10 , C07D403/14 , C07D405/14 , C07D409/04 , C07D409/14 , C07D487/04 , C07D491/16 , C07D209/02
CPC分类号: C07D401/14 , C07D209/44 , C07D209/52 , C07D209/72 , C07D405/14 , C07D409/04 , C07D409/14 , C07D487/04
摘要: Compounds of formula (I): ##STR1## wherein: R represents hydrogen, alkyl, optionally-substituted amino, or linear or branched (C.sub.1 -C.sub.6)-acyl,R.sub.1 and R.sub.2, which may be identical or different, each represents independently of the other aryl, heteroaryl, or (C.sub.5 -C.sub.7)-cycloalkyl, or one of those groups optionally substituted,A, together with the atoms in common with the pyrrole, represents saturated or unsaturated, monocyclic or bicyclic (C.sub.3 -C.sub.12)-cycloalkyl, or a saturated heterocycle having 5 to 7 ring members and containing one or two nitrogen, or 7-oxabicyclo[2.2.1]heptane, or one of those groups optionally substituted,their isomers, and also addition salts thereof with a pharmaceutically-acceptable acid or base, pharmaceutical compositions thereof, and use thereof as medicaments.
摘要翻译: 式(I)的化合物:其中:R表示氢,烷基,任选取代的氨基或直链或支链(C 1 -C 6) - 酰基,可以相同或不同的R 1和R 2各自独立地表示其它芳基 ,杂芳基或(C5-C7) - 环烷基,或任选取代的那些基团之一,A与与吡咯共同的原子一起代表饱和或不饱和的单环或双环(C 3 -C 12) - 环烷基或 饱和杂环,其具有5至7个环成员并含有一个或两个氮或7-氧杂双环[2.2.1]庚烷,或任选取代的那些基团之一,其异构体,以及其与药学上可接受的酸或碱的加成盐 ,其药物组合物及其作为药物的用途。
-
-
-
-
-
-